Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Depreciation and Depletion (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Depreciation and Depletion for 7 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 45.0% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Dec 2025, up 12.16% year-over-year, with the annual reading at $8.3 million for FY2025, 12.16% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $2.9 million at Kymera Therapeutics, up from $2.1 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $2.9 million in Q4 2025, with the low at $700.0 in Q3 2021.
  • Average Depreciation and Depletion over 5 years is $1.3 million, with a median of $900000.0 recorded in 2023.
  • The sharpest move saw Depreciation and Depletion plummeted 99.86% in 2021, then soared 114185.71% in 2022.
  • Over 5 years, Depreciation and Depletion stood at $2.4 million in 2021, then tumbled by 66.64% to $800000.0 in 2022, then rose by 12.5% to $900000.0 in 2023, then skyrocketed by 122.22% to $2.0 million in 2024, then soared by 45.0% to $2.9 million in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $2.9 million, $2.1 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.